Rivaroxaban Granule
Factor Xa Inhibitor
NADAC/unit
$1.9574
No Shortage
Rivaroxaban Granule prevents blood clots by inhibiting factor Xa, prescribed for atrial fibrillation and venous thromboembolism.
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
